SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is currently trending as investors monitor significant insider selling alongside a broader sector rotation that has sent major semiconductor and memory names reeling this week. The community remains deeply divided, with some traders debating the validity of bearish short signals and others emphasizing that Applied Materials' role in the long-term AI infrastructure build-out makes recent dips a potential buying opportunity.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital is facing intense scrutiny and bearish sentiment from investors frustrated by lagging stock performance and perceived management failures, despite ongoing efforts to pivot toward AI and data center infrastructure. The community is sharply divided between long-term holders waiting for a strategic breakout and critics calling for a leadership change, all while the stock faces significant volatility linked to Bitcoin's price movements and heavy short interest.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is facing significant selling pressure and sustained negative sentiment as investors react to concerns over heavy dilution, aggressive executive compensation packages, and a lack of new customer contract announcements. While bulls maintain conviction in the long-term potential of the company's AI infrastructure and power capacity buildout, the stock is currently struggling against broad sector volatility and heavy short interest.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is attracting intense investor attention following a high-profile industry report suggesting potential U.S. import restrictions on Chinese power inverters, a policy shift that could benefit domestic manufacturers. Community discussions remain highly polarized, balancing excitement over the company's emerging role in AI data center power infrastructure against frustrations with the stock's extreme volatility and significant short interest.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solar is garnering significant investor attention as community members debate its potential for a major re-rating driven by U.S. manufacturing expansion and the long-term benefit of Section 45X tax credits. While some investors are actively accumulating shares at current price levels based on a bullish long-term outlook for renewable energy and storage, others are expressing frustration over stagnant price performance and high short interest, leading to intense community discussion regarding potential market manipulation and the company's valuation gap compared to its industry peers.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is seeing renewed interest as investors pivot toward its potential for differentiated, long-lasting results in the dermatology space, with the community closely tracking upcoming maintenance data releases as a key catalyst. Shareholders remain focused on the company's robust cash position and the ongoing legal developments with Eli Lilly, balancing high conviction in the pipeline's clinical potential against long-term frustration over management's history of dilution and share price volatility.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is experiencing significant volatility as investors rotate out of memory and semiconductor stocks amidst concerns over profit-taking and sector-wide cooling. The community remains divided, with many debating whether the current sell-off is a healthy reset of an overextended AI infrastructure trade or a sign of deeper structural headwinds ahead of upcoming earnings.

Bitzero Holdings, Inc. engages in providing IT energy infrastructure and power for data centers. It focuses on data center development, Bitcoin mining, and obtaining strategic data center hosting partnerships. It operates data centers located in Namsskogan, and Røyrvik, Norway, Finland, and North Dakota, U.S.A. The company was founded on October 20, 2025 and is headquartered in Vancouver, Canada.

Bitzero Holdings Inc.

Bitzero Holdings is gaining investor interest as a potential infrastructure play in the artificial intelligence sector, with community discussion centered on its secured renewable power capacity and a multi-billion dollar data center lease in the Nordics. Investors are actively monitoring the stock for official contract finalizations and potential partnerships with major technology companies that could validate its AI-focused business model.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The Dow Jones Industrial Average is currently a central focus of market discussion as investors weigh the impact of shifting geopolitical tensions in the Middle East against a resilient labor market and robust corporate earnings. Community sentiment is deeply polarized, with some traders highlighting the index's record-breaking momentum and tech-driven rallies, while others warn of significant economic risks and potential volatility stemming from ongoing conflicts and inflation concerns.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Mining is seeing renewed investor interest as community sentiment shifts toward its strategic pivot into high-performance computing, with traders monitoring critical resistance levels and long-term contract validation with major hyperscalers. While technical analysts view recent price action as a healthy consolidation within an established uptrend, participants remain focused on potential near-term catalysts like future earnings and grid expansion news as the primary drivers for price discovery.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GSK plc (GSK) Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share

GSK plc (GSK) Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share...

FDA Expands IONS' Tryngolza Label to Treat Severe Hypertriglyceridemia

Ionis wins FDA approval to expand Tryngolza to severe hypertriglyceridemia, opening a broader market as the first approved treatment for the condition. 

GSK Commences Tender Offer To Acquire Nuvalent For $124 Per Share

(RTTNews) - GSK plc (GSK) said Wednesday that its indirect wholly-owned subsidiary, Harmony Row Acquisition Co., has commenced a tender offer to acquire all outstanding shares of Nuvalent Inc. (NUVL) for $124.00 per share in cash...

Top Analyst Reports for Micron Technology, Coca-Cola & Arista Networks

MU, KO and ANET headline Zacks' latest analyst reports, with AI demand, pricing gains and networking expansion driving the outlook.

Brains, AI Imaging, and Breakthrough Antibiotics Ignite Investor Buzz

The healthcare and biotechnology sector continues to generate a steady stream of meaningful catalysts as companies advance novel therapies, secure regulatory milestones, strengthen intellectual property portfolios, and expand commercialization efforts. Recent developments from CervoMed (NASDAQ:CRVO), Butterfly Network (NYSE:BFLY), NeOnc (NASDAQ:NTHI), Spero Therapeutics (NASDAQ:SPRO), GSK (NYSE:GSK), and IceCure Medical (NASDAQ:ICCM) highlight several emerging themes shaping the sector, including neurodegenerative disease treatment, AI-powered diagnostics, antimicrobial resistance, minimally invasive cancer care, and synthetic biology.

Biogen to Strengthen Immunology Pipeline With $1B RayThera Buyout

BIIB is set to acquire RayThera for up to $1 billion, adding anti-inflammatory candidates that could expand its immunology pipeline and future growth.

GSK's Utebzi Wins FDA Nod for Complicated Urinary Tract Infections

GSK wins FDA approval for Utebzi, the first oral carbapenem for complicated UTIs, further expanding its anti-infectives portfolio.

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

GSK plc (LSE/NYSE: GSK) and Spero Therapeutics (Nasdaq: SPRO) today announced that the US Food and Drug Administration (FDA) has approved Utebzi, an oral antibiotic for the treatment of complicated urinary tract infections (cUTIs) including pyelonephritisi, caused by certain susceptible pathogensii...

GSK, Spero Win FDA Nod For First-Ever Oral Carbapenem Antibiotic For Complicated UTIs

FDA approves GSK and SPRO's Utebzi, the first oral carbapenem for cUTIs. Launch planned for late 2026. See market reaction.read more...

The Zacks Analyst Blog Highlights Gilead Sciences, Merck and GSK

Gilead Sciences won FDA acceptance for a filing that could expand Yeztugo into a once-weekly oral HIV prevention option, broadening its HIV portfolio.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

GSK Plc - ADR

NUVL Stock Surges 39% Premarket – Why Is GSK Buying This Boston-Based Oncology Company?

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

GSKGlaxosmithkline plc - ADR

Fundamentals

Latest GSK News